EverQuote CEO Mendal exercises $6.96 options, sells
The November 2 option exercise and sales were under a Rule 10b5-1 plan adopted June 16, 2026; the November 4 exercise was outside that plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EverQuote, Inc. (EVER) CEO and President Jayme Mendal exercised options for 11,406 shares at $6.96 per share on November 2, 2026, and sold 18,157 shares at a weighted average $23.82 and 2,824 shares at a weighted average $24.27. The November 2 option exercise and sales were under a Rule 10b5-1 plan adopted June 16, 2026. On November 4, he exercised options for 28,725 shares at $6.96, paid the exercise price in cash, and retained all shares acquired; that exercise was outside the plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F4, F5 | 28,725 | $6.96 | $200K |
| Exercise | Class A Common Stock F4 | 28,725 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F1, F5 | 11,406 | $6.96 | $79K |
| Exercise | Class A Common Stock F1 | 11,406 | $0.00 | $0.00 |
| Sale | Class A Common Stock F1, F2 | 18,157 | $23.82 | $432K |
| Sale | Class A Common Stock F1, F3 | 2,824 | $24.27 | $69K |
Footnotes (5)
- F1. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.22 to $24.21, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.22 to $24.32, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- F4. The reporting person exercised this option outside of a Rule 10b5-1 trading plan and paid the exercise price in cash. The reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise.
- F5. This option was granted on October 18, 2017. 25% of the shares underlying the option vested on September 30, 2018, with the remaining shares vesting monthly thereafter over the following three years.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (right to buy) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.